about
Olfactory marker protein expression is an indicator of olfactory receptor-associated events in non-olfactory tissuesVasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs InflammationEarly prediction of long-term response to cabergoline in patients with macroprolactinomasAssociation between low-grade albuminuria and cardiovascular risk in Korean adults: the 2011-2012 Korea National Health and Nutrition Examination SurveyAssociation between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011-2012 Korean National Health and Nutrition Examination Survey.GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinomaAberrant expression of COT is related to recurrence of papillary thyroid cancer.Therapeutic effects of water soluble danshen extracts on atherosclerosis.The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown AdipocytesAssociation Between Hearing Impairment and Albuminuria in the Korean Adults: The 2011-2012 Korea National Health and Nutrition Examination SurveyNo differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study).Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases.Characteristics of acromegaly in Korea with a literature review.Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets.KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice.Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab 2016;31:328-35, Cheol Ryong Ku et al.).FoxO1 is a negative regulator of FSHβ gene expression in basal and GnRH-stimulated conditions in female.A case of fugitive acromegaly, initially presented as invasive prolactinoma.Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.Clinical predictors of GH deficiency in surgically cured acromegalic patients.Different CXCR4 expression according to various histologic subtype of papillary thyroid carcinoma.A Selective Cyclin-Dependent Kinase 4, 6 Dual Inhibitor, Ribociclib (LEE011) Inhibits Cell Proliferation and Induces Apoptosis in Aggressive Thyroid Cancer.Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm.Age- and Sex-Specific Differences as Predictors of Surgical Remission among Patients with Acromegaly.Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas.Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas.Association Between Obesity and BRAFV600E Mutation Status in Patients with Papillary Thyroid Cancer.Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy.Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase.Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling.Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs.Comparative assessment of Graves' disease and main extrathyroidal manifestation, Graves' ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue.Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adultsMedical Treatment with Somatostatin Analogues in Acromegaly: Position StatementExtracapsular en bloc resection in pituitary adenoma surgeryOutcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus InvasionAdrenocorticotropic Hormone-Secreting Esthesioneuroblastoma with Ectopic Cushing's Syndrome
P50
Q28543153-9CA8AF3F-5FD2-49C7-A68F-7CB0DADE7E09Q28550935-0C8A6F0A-48B4-404F-A824-6C9702876F1FQ34318860-32D97FE6-2135-4D0F-900F-B85180A57463Q35151854-C0385807-3249-4657-83A4-13515874CCCAQ35642055-879FE191-8AC4-4A05-80DE-036C5DC9319FQ35857790-D629E289-377F-48EA-8B03-5997E76AD882Q36151455-D9D8591A-5485-444B-84CB-37237AECB8A2Q36152396-A74715DE-8B8F-4A11-ABCE-61ADAF49C9DEQ36582676-577CCDFE-309C-4CCE-870C-79CDFFDB1BD4Q37043646-90CC3EF3-00AC-4D61-9125-322A4CE1D1AEQ37176259-3D7B40D4-542A-460D-8948-EFA49CB7C72CQ37205596-3E397B2F-C3A4-467A-9198-38234E3AD4E7Q37206875-B753302F-F2AD-4362-8AF6-16B8931F7EF2Q38176366-5C010C6F-5388-4A36-A170-413BF78780A6Q38895673-B7098F5F-975C-4652-A497-CC6EF0353DCCQ38917901-742EC33A-4844-4C7F-80CE-7EB4F2FAF6D5Q39621495-68F41B8B-EBDC-41A9-A896-ED3B0F1BCC47Q42386750-D65785EB-1FAE-4631-BD49-1E25CAAF3248Q42452638-C8B003E2-B24F-4312-BD2F-807C9887566CQ42478613-C45A5C84-FE9E-4A5F-86AE-8294B0F847D0Q44441553-B13C6FD3-E6F0-4E29-BB60-7C29CB84FDF1Q45999192-E19CB830-B1FD-465D-B818-170A1CEAF933Q46874389-0852F282-4CB1-4834-9742-ECDF45B198BAQ47202838-9321FE67-9C44-475C-B8DA-D2A500B2CD13Q47441842-AA1DD15B-4C90-49D3-A3D2-0A221379C22FQ47560645-7CF50ECC-BA46-40A3-BF96-0427E9A706AEQ48153946-906A78DE-62BD-4CD5-B114-60416DCBDB9BQ49860472-6E508A08-E8B2-4C6D-98DA-4FAB76CBCD1CQ51001072-F2D22F22-4B67-4DCC-9F48-1354616A3328Q51275736-EEECC645-56DC-4547-AF2A-75432924A642Q51365649-2CB36C88-AD2F-4E7B-AD14-C9516CB677DFQ52738997-F2D639F3-0F7C-42BD-89B2-83D341C27093Q53072406-068D961C-9C38-40B0-990A-1F406DECD024Q54117338-97B0C2D9-057E-48C5-A7B0-D40A7DC14EF0Q55344960-8ADFE944-7D70-4977-9B38-F6741D431FB6Q56967663-A44A0457-3F7F-48BC-B63C-7DD03E1F6291Q64064994-A9DBE591-FB8F-4CCE-AC40-6C8DA19CFE04Q87448412-EF514E52-B22A-4F0A-AD71-FCF5DDCA91CFQ89115792-46D10650-860E-47EF-9B98-B2FF9D7C1E60Q89894860-85732F77-044A-4577-B475-42ACE3FCECAC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cheol Ryong Ku
@ast
Cheol Ryong Ku
@en
Cheol Ryong Ku
@es
Cheol Ryong Ku
@nl
Cheol Ryong Ku
@sl
type
label
Cheol Ryong Ku
@ast
Cheol Ryong Ku
@en
Cheol Ryong Ku
@es
Cheol Ryong Ku
@nl
Cheol Ryong Ku
@sl
prefLabel
Cheol Ryong Ku
@ast
Cheol Ryong Ku
@en
Cheol Ryong Ku
@es
Cheol Ryong Ku
@nl
Cheol Ryong Ku
@sl
P106
P31
P496
0000-0001-8693-9630